scholarly journals “Is powered toothbrush better than manual toothbrush in removing dental plaque?” – A crossover randomized double-blind study among differently abled, India

2017 ◽  
Vol 21 (2) ◽  
pp. 138
Author(s):  
ByalakereRudraiah Chandrashekar ◽  
Mallam Neelima ◽  
Shubhi Goel ◽  
Rudraswamy Sushma ◽  
Yarramasu Srilatha
Keyword(s):  
Dental Plaque ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Manual Toothbrush ◽  
Powered Toothbrush ◽  
Better Than

Comparative Efficacy of Lormetazepam (Noctamid®) and Diazepam (Valium®) in 100 Out-Patients with Insomnia

1981 ◽  
Vol 9 (3) ◽  
pp. 199-202 ◽  
Author(s):  
M Sastre y Hernández ◽  
H-D Hentschel ◽  
K Fichte
Keyword(s):  
Side Effects ◽  
Sleep Disorders ◽  
Blind Study ◽  
Double Blind Study ◽  
Comparative Efficacy ◽  
Double Blind ◽  
Better Than

Lormetazepam (Noctamid®) at a dosage of 1 mg was compared with diazepam (Valium®) at a dosage of 5 mg in a 7-day double-blind study. The study involved fifty patients in the lormetazepam group and fifty patients in the diazepam group. All the patients were suffering from sleep disorders as a concomitant symptom of general diseases. Lormetazepam was significantly better than diazepam in the: Reduction of the time taken to fall asleep (p < 0.05) Prolongation of the duration of uninterrupted sleep (p < 0.05) Reduction of the frequency of awakening (p < 0.05) Lormetazepam displayed no hang-over effects or other side-effects and, in this respect too, was significantly superior to diazepam (p < 0.05).

Effervescent Metoclopramide and Aspirin (Migravess) Versus Effervescent Aspirin or Placebo for Migraine Attacks: A Double-Blind Study

Cephalalgia ◽  
1984 ◽  
Vol 4 (2) ◽  
pp. 107-111 ◽  
Author(s):  
Peer Tfelt-Hansen ◽  
Jes Olesen
Keyword(s):  
Migraine Attack ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Significant Difference ◽  
Better Than

Aspirin 650 mg and metoclopramide 10 mg in an effervescent preparation (Migravess(r)) were compared with effervescent aspirin 650 mg (Alka-Seltzer(r)) and placebo for common migraine attacks with a double-blind cross-over design. One hundred and eighteen patients with common migraine were entered. Eighty-five patients completed all three forms of treatment, eleven completed two, and six completed one. Medicine was taken when patients were sure they had a migraine attack and not just interval headache. After each form of treatment, they mailed a report form to the investigators. Additional medication was allowed after 2 h and was taken for 79/95 placebo treated attacks, 63/92 Migravess treated attacks, and 51/86 aspirin treated attacks (p < 0.01). Aspirin was significantly better than placebo for pain but not quite significant for nausea. Migravess(r) was significantly better than placebo for pain and for nausea. There was no significant difference between aspirin and Migravess(r) with regard to analgesic effectiveness (p = 0.33) or to antinausea effect (p = 0.18).

Sign in / Sign up

Export Citation Format

Share Document